PT  - JOURNAL ARTICLE
AU  - Marin, Julie
AU  - Bertoye, Paul Albin
AU  - Birgy, Andre
AU  - Dziri, Samira
AU  - Lescat, Mathilde
TI  - Validation of rectal swabbing for total and aerobic gut microbiota study
AID  - 10.1101/2024.07.22.24310623
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.07.22.24310623
4099  - http://medrxiv.org/content/early/2024/07/22/2024.07.22.24310623.short
4100  - http://medrxiv.org/content/early/2024/07/22/2024.07.22.24310623.full
AB  - In microbiota research, whole stool sampling is the conventional approach but can be problematic or infeasible for certain patients. This study aims to validate the use of rectal swabbing as an alternative method for microbiota analysis and determine optimal storage conditions suitable for various clinical settings, including intensive care units. We evaluated different sampling techniques, conservation media and storage temperatures. Our findings indicated that rectal swabs yield microbiota diversity comparable to whole stool samples. Notably, storage conditions significantly impacted microbiota profiles, with increased E. coli and Enterococcus sp. quantifications observed at room temperature. Consequently, we recommend immediate refrigeration of rectal swabs to reliably assess aerobic and total microbiota, particularly for patients requiring urgent care such as antibiotic treatment.Importance We developed a pragmatic approach to study total and aerobic gut microbiota, applicable in numerous clinical units such as intensive care or emergency units, where whole stool sampling is often impractical. This approach employs ESwab™ devices which are already commonly used in hospital.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:In accordance with APHP (Assistance publique Hopitaux de Paris) ethics regulations and the Declaration of Helsinki, all participants received comprehensive information and provided consent. All individuals were collected thanks to ethical authorization CLEA number 2019-72 obtained by the Comite local de Protection des Personnes des hopitaux universitaires de Paris Seine Saint Denis.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors